Ruxolitinib in the Treatment of Covid-19
Clinical trial NCT04414098 · UNKNOWN
Trial details
- NCT number
- NCT04414098
- Sponsor
- Marcelo Iastrebner
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2020-08-15
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.